CD274 and neoplasm: Among patients with tumor PD-L1 score (TPS) recorded (n = 211 [53%]; due to the historical nature of the dataset, PD-L1 testing was not done in 117 patients [30%] and unknown in the remaining 68 patients [17%]), 57 (27%) had <1% expression, 49 (23%) had 1% to 49% expression, and 105 (49%) had 50% or greater expression.